![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/27/2905124/0/en/Aquestive-Therapeutics-to-Participate-in-Leerink-Partners-Therapeutics-Forum-I-I-and-Metabolism.html
https://www.globenewswire.com/news-release/2024/06/25/2903743/0/en/Aquestive-Therapeutics-Reports-Positive-Topline-Data-from-Temperature-pH-Study-of-Anaphylm-epinephrine-Sublingual-Film.html
https://www.globenewswire.com/news-release/2024/06/18/2900350/0/en/Aquestive-Therapeutics-to-Join-the-Russell-3000-and-Russell-2000-Indexes-Effective-June-28-2024.html
https://www.globenewswire.com/news-release/2024/06/03/2892173/0/en/Aquestive-Therapeutics-Announces-Executive-Appointments-and-Builds-Commercial-Capabilities.html
https://www.globenewswire.com/news-release/2024/05/28/2888980/0/en/Aquestive-Therapeutics-to-Present-Anaphylm-epinephrine-Sublingual-Film-Pharmacokinetic-and-Pharmacodynamic-Data-At-2024-Eastern-Allergy-Conference.html
https://www.globenewswire.com/news-release/2024/05/09/2878682/0/en/Aquestive-Therapeutics-to-Participate-in-The-Citizens-JMP-Life-Sciences-Conference.html
https://www.globenewswire.com/news-release/2024/05/07/2877273/0/en/Aquestive-Therapeutics-Reports-First-Quarter-2024-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com/news-release/2024/04/25/2869581/0/en/Aquestive-Therapeutics-to-Report-First-Quarter-2024-Financial-Results-and-Recent-Business-Highlights-on-May-7-and-Host-Conference-Call-on-May-8-at-8-00-a-m-ET.html
https://www.globenewswire.com/news-release/2024/04/12/2862377/0/en/Aquestive-Therapeutics-to-Present-Crossover-Study-Data-for-Libervant-diazepam-Buccal-Film-at-76th-Annual-Meeting-of-the-American-Academy-of-Neurology.html
https://www.globenewswire.com/news-release/2024/04/01/2855154/0/en/Aquestive-Therapeutics-Strengthens-Board-of-Directors-with-Experienced-Biotech-Executive.html